Perspective Therapeutics (CATX) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,050.00 |
| Dec 31, 2025 | -1,317.00 |
| Sep 30, 2025 | 696.00 |
| Jun 30, 2025 | 1,225.00 |
| Mar 31, 2025 | 1,672.00 |
| Dec 31, 2024 | 2,329.00 |
| Sep 30, 2024 | 4,042.00 |
| Jun 30, 2024 | 4,402.00 |
| Mar 31, 2024 | 4,007.00 |
| Dec 31, 2023 | 1,434.00 |
| Sep 30, 2023 | 4,387.00 |
| Jun 30, 2023 | 8,571.00 |
| Mar 31, 2023 | 5,521.00 |
| Dec 31, 2022 | 4,530.00 |
| Sep 30, 2022 | 4,441.00 |
| Jun 30, 2022 | 4,083.00 |
| Mar 31, 2022 | 3,668.00 |
| Dec 31, 2021 | 3,262.00 |
| Sep 30, 2021 | 3,042.00 |
| Jun 30, 2021 | 2,700.00 |
| Mar 31, 2021 | 1,734.00 |
| Jun 30, 2019 | -4,133.00 |
| Mar 31, 2019 | -3,980.00 |
| Dec 31, 2018 | -847.00 |
| Sep 30, 2018 | -1,857.00 |
| Jun 30, 2018 | -5,027.00 |
| Mar 31, 2018 | -2,845.00 |
| Dec 31, 2017 | -2,233.00 |
| Sep 30, 2017 | -1,488.00 |
| Jun 30, 2017 | -41.00 |
| Mar 31, 2017 | 355.00 |
| Dec 31, 2016 | 1,045.00 |
| Sep 30, 2016 | 1,470.00 |